ANTI-TUBERCULOSIS DRUG RESISTANCE IN SOUTHEAST OF TURKEY
dc.contributor.author | Dal, Tuba | |
dc.contributor.author | Ozcan, Nida | |
dc.contributor.author | Tekin, Recep | |
dc.contributor.author | Tekin, Alicem | |
dc.contributor.author | Celen, Mustafa Kemal | |
dc.contributor.author | Ozekinci, Tuncer | |
dc.contributor.author | Dal, T. | |
dc.date.accessioned | 2024-04-24T17:44:36Z | |
dc.date.available | 2024-04-24T17:44:36Z | |
dc.date.issued | 2013 | |
dc.department | Dicle Üniversitesi | en_US |
dc.description.abstract | Objective: Tuberculosis is a globally prevalent life-threatening infectious disease. In this study we aimed to evaluate antibiotic suscebtibility rates of Mycobacterium tuberculosis complex strains. Materials and methods: A total of 150 culture-positive samples were included in. Among culture positive samples 86 were Mycobacterium tuberculosis complex and 64 were non-tuberculous mycobacterium. Of Mycobacterium tuberculosis complex isolated samples 45 were Ziehl-Neelsen positive. Of 64 non-tuberculous mycobacterium isolated samples 15 were Ziehl-Neelsen positive. Mean age of the patients with tuberculosis was 37.74 +/- 20.53 and non-tuberculous mycobacterium isolated patients was 46.80 +/- 23.32. Antibiotic susceptibility testing was performed for the four first-line anti-tuberculosis drugs by BACTEC MGIT-960 instrument (Becton Dickinson). Of M. tuberculosis strains 41 % was resistant to at least one or more of the drugs (isoniasid 27.9%, ethambutol 8.13%, streptomycin 12.79 %, rifampicine 9.3 %). Of the strains 5.8 % was resistant to two, 3.4 % to three and 3.4 % to four drugs. Conclusion: Mycobacterium tuberculosis complex and drug resistance of this microorganism continued to be a problem for our country and non-tuberculous mycobacterium species may become a problem in the future. We thought that a strong and cost-effective tuberculosis control programme contributes to reduce the incidence of drug resistance in the community. | en_US |
dc.identifier.endpage | 46 | en_US |
dc.identifier.issn | 0393-6384 | |
dc.identifier.issue | 1 | en_US |
dc.identifier.startpage | 41 | en_US |
dc.identifier.uri | https://hdl.handle.net/11468/22180 | |
dc.identifier.volume | 29 | en_US |
dc.identifier.wos | WOS:000337927000006 | |
dc.identifier.wosquality | Q4 | |
dc.indekslendigikaynak | Web of Science | |
dc.language.iso | en | en_US |
dc.publisher | Carbone Editore | en_US |
dc.relation.ispartof | Acta Medica Mediterranea | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Mycobacterium Tuberculosis | en_US |
dc.subject | Susceptibility | en_US |
dc.subject | First-Line Antibiotics | en_US |
dc.title | ANTI-TUBERCULOSIS DRUG RESISTANCE IN SOUTHEAST OF TURKEY | en_US |
dc.title | ANTI-TUBERCULOSIS DRUG RESISTANCE IN SOUTHEAST OF TURKEY | |
dc.type | Article | en_US |